Article: The Biology and Therapeutic Potential of Nicotinamide Riboside and Nicotinamide Mononucleotide: Review

PrevNext
Cellular Health Healthy Aging & Longevity Review

The Biology and Therapeutic Potential of Nicotinamide Riboside and Nicotinamide Mononucleotide: Review

Synopsis

Research on NAD+ biology has surged, especially around two intermediates—nicotinamide riboside (NR) and nicotinamide mononucleotide (NMN)—which show promise in preventing and treating age-related conditions. While their exact metabolism and tissue-specific behavior are still being clarified, studies suggest that their effectiveness depends on where NAD-related enzymes, nucleotidases, and transporters are most active. A new framework now links NAD+ metabolism directly to aging and longevity, and the challenge ahead is to translate strong preclinical results into proven health benefits for humans.

JOURNAL

Cell Metabolism

Share

Read more

Clinical

Nicotinamide Riboside Supplementation Increases Blood NAD+ Levels in Healthy Humans: Clinical Findings

Objectives To determine the human pharmacokinetics of NR supplementation and its effect on whole blood nicotinamide adenine dinucleotide (NAD+) levels. Journal PLoS ONE Key Outcomes NR supplement...

Read more
Cellular Health

Therapeutic Potential of NAD-Boosting Molecules: Review

SynopsisNicotinamide adenine dinucleotide (NAD+) is best known as a hydrogen carrier in energy-producing reactions, but it also acts as a signaling molecule that controls hundreds of vital processe...

Read more